Litigation Details for United States v. Holmes (N.D. Cal. 2018)
✉ Email this page to a colleague
United States v. Holmes (N.D. Cal. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-06-14 |
Court | District Court, N.D. California | Date Terminated | 2022-12-07 |
Cause | Assigned To | Edward John Davila | |
Jury Demand | Referred To | Susan G. Van Keulen | |
Parties | ADAM ROSENDORFF; RAMESH "SUNNY" BALWANI; USA | ||
Patents | 10,030,059; 10,036,037; 10,046,000; 10,522,245; 6,002,008; 6,005,001; 6,660,267; 7,345,014; 8,008,006; 8,013,002; 8,044,014; 9,000,011; 9,000,038; 9,026,372; 9,040,034; 9,056,057; 9,056,059; 9,399,023; 9,415,050; 9,529,976 | ||
Attorneys | Amanda Mariam McDowell; Benjamin J. Byer; Jeffrey Benjamin Schenk; Jeffrey Bruce Coopersmith; John Curtis Bostic; Joshua Thomas Ferrentino; Kelly Michelle Gorton; Mark Nelson Bartlett; Max Bamberger Hensley; Robert S. Leach; Stephen Anthony Cazares; Steven Fogg | ||
Firms | Corr Cronin LLP; Davis Wright and Tremaine; Davis Wright Tremaine LLP; Quinn Emanuel Urquhart & Sullivan, LLP; United States Attorney's Office; United States Attorney's Office, Northern District of California; US Attorney's Office, Northern District of California | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United States v. Holmes
Biologic Drugs cited in United States v. Holmes
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for United States v. Holmes (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-09-07 | 1002 | Exhibit List | USP 10,522,245 HOLMES005214 HOLMES005301… Perkins Coie Presentation: Theranos, Inc. Patent Portfolio PC0000048 … D. Taylor Email to A. Shah et al. re Theranos Patent List (with FIG00000703 FIG00000778…"Boies Schiller & Flexner Adds Two Top Patent Litigators" HOLMES002431 HOLMES002433 | External link to document |
2022-01-18 | 1271 | Transcript | AND THEN REMOVING TWO OF THEM AND AVERAGING THE 10:30:59 16 REST? 10:31:00 17 A. YES. …DURING CROSS-EXAMINATION ABOUT 10:30:05 23 PATENTS HELD BY THERANOS? 10:30:07 24 A. YES.…08 25 Q. YOU SAID THAT THERANOS'S PATENTS, WHEN YOU WERE DECIDING …, AND JUST RELIED ON THOSE 10:30:27 6 PATENTS AS EVIDENCE THAT THE TESTS WERE ACCURATE? 10:30… DOES THE FACT THAT A BLOOD TESTING METHOD IS PATENTED MEAN 10:30:36 9 THAT IT'S ACCURATE | External link to document |
2022-05-31 | 1469 | Order | WOULD BE, IF WE'RE ABLE TO, WE WOULD BEGIN AT 9:00 11:07AM 6 AND THEN END AT 3:00 TOMORROW. … 01:26PM 4 PATENTS? 01:26PM 5 A. AGAIN, I'M NOT A PATENT ATTORNEY. I CAN…25PM 19 Q. DID YOU ALSO LOOK AT THE PATENTS THAT THERANOS HAD 01:25PM 20 OBTAINED?… SOME WORK TO TRY TO UNDERSTAND THE BREADTH OF PATENTS. 01:25PM 23 Q. OKAY. AND DO YOU …01:25PM 25 A. AGAIN, I'M NOT A PATENT ATTORNEY EITHER. MY RECOLLECTION | External link to document |
2022-11-10 | 1642 | Exhibit H | US 9,529,976 …Agreement Theranos’ US Patent Portfolio Is Young Theranos has a young patent portfolio, with US expiration…Detection Technology Patents Theranos’ core technologies enjoy robust patent protection … Patent Coverage Technology Patent Coverage … US Patent Classification US Patent Classification | External link to document |
2022-11-11 | 1645 | Exhibits | 17.5% 4.9% 3.2% 34.9% 20.3% 15.6% 2.8% 0.11098 1.47 135.5% -142.1%… all assets of the Company including its patents and patent applications 5. Fortress made this loan… 169,583 Legal Regulatory and Patents Costs 313,058 100% … 43,792 Legal Regulatory and Patents Costs 1,750,963 100% … 169,583 Legal Regulatory and Patents Costs 313,058 100% | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |